MedPath

Oregon Health and Science University

Oregon Health and Science University logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Study Identifies Why Venetoclax-Based AML Treatment Fails in Certain Patients

Researchers analyzed 678 AML patients and found that both gene mutations and leukemia cell maturity affect response to venetoclax plus hypomethylating agents treatment.

Precede Biosciences Unveils Breakthrough Liquid Biopsy Platform for Tumor Gene Expression at AACR 2025

Precede Biosciences has developed a comprehensive epigenomic liquid biopsy platform capable of predicting expression of over 2,500 tumor-specific genes from just 1mL of blood plasma.

OB/GYN Workforce Shifts Following Abortion Bans: New Study Reveals Complex Migration Patterns

A new JAMA Network Open study reveals that while most OB/GYNs didn't immediately leave states with abortion bans after the 2022 Dobbs ruling, a significant decline is now occurring in the 12 most restrictive states.

Cancer Drug Use Rapidly Declines Following Withdrawal of FDA Accelerated Approval

A new study reveals significant decreases in oncology medication use after negative confirmatory trials are published, despite drugs remaining available for other indications.

NIH Launches CARE for Health Network to Enhance Primary Care Research

The NIH is investing $30 million to launch the CARE for Health network, aimed at integrating clinical research with community-based primary care.

© Copyright 2025. All Rights Reserved by MedPath